Bowie, Md., USA - November 3, 2010, Bowie, Md., USA - MedAssurant Inc., a software company, announced four additions to its executive management ranks.
Article continues below
David Finkel has joined MedAssurant as the Chief Operating Officer where he is responsible for the planning, management, and oversight of all product and service fulfillment operations, quality adherence operations, human resources, facilities, and administration across all aspects of the Company.
Prior to joining MedAssurant, Mr. Finkel served as Senior Vice President of Service Operations at WellPoint, Inc., the nation’s largest health benefits company. Preceding this position at WellPoint, Mr. Finkel served as Senior Vice President of Service Operations and Chief Executive Officer of Management Services for Coventry Health Care. Before his tenure at Coventry, Mr. Finkel served in numerous executive roles at companies including Cigna Healthcare, HealthMarket, Inc., Deloitte & Touche, and Oxford Health Plans.
Mr. Hammad Shah has joined MedAssurant as the Chief Strategy Officer where he holds the responsibility for the strategy, design, development, implementation, operations, and expansion of the Company’s core products, as well as the Company’s strategic partnerships and alliances, acquisitions, international growth initiatives, and the support of the Company’s broader strategic initiatives.
Prior to joining MedAssurant, Mr. Shah served as Vice President and General Manager of Emerging Markets for Express Scripts, one of the healthcare industry’s largest pharmacy benefit management companies. At Express Scripts Mr. Shah was responsible for the strategy and leadership of five business units spread across clinical, distribution operations, and consumer directed health market operations.
Prior to this, Mr. Shah was Vice President of Strategy and Business Development, International Operations at Express Scripts where he lead the organization’s global strategy and business development with specific emphasis on Europe and the Far East.
Mr. Luis Gutierrez, Jr. has joined MedAssurant as a Senior Vice President of Pharmaceutical and Life Sciences Operations where he is responsible for the coordination, achievement, and operational management of the Company’s pharmaceutical, life sciences, diagnostics, medical device, and related data registries business and product lines.
Prior to joining MedAssurant, Mr. Gutierrez served as President of Periapproval and Market Access Services at Covance Inc., one of the industry’s largest contract research organizations (CRO). In this position, Mr. Gutierrez oversaw the analytical, operational, financial, and managerial planning and execution of randomized clinical trials, prospective observational studies, and restrospective analysis of healthcare datasets and registries on a global basis.
Prior to serving as president, Mr. Gutierrez held roles as Covance’s Vice President and General Manager of Market Access Services, and Vice President of Health Economics and Outcomes Research Services. Prior to joining Covance in 1991, Mr. Gutierrez worked in Business Development with Merck & Company.
Dr. Stephen DeCherney has joined MedAssurant as a Senior Vice President of Pharmaceuticals and Life Sciences where he holds responsibility for supporting the strategy, design, development, implementation, operations, and expansion of the Company’s pharmaceuticals, life sciences, diagnostics, and medical device business and product lines.
Prior to joining MedAssurant, Dr. DeCherney served as Chief Innovation Officer for Quintiles Transnational Corp., the industry’s largest CRO where he was responsible for design and execution of approaches to clinical trials within the pharmaceutical industry. Previously at Quintiles, Dr. DeCherney served as President of Clinical Development Services overseeing Global Clinical Development Services, Global Data Management, and Global Drug Safety and Strategic Research Services. ■